Evidence-based emergency medicine/systematic review abstract. Use of low molecular weight heparins in patients with acute venous thromboembolism

Ann Emerg Med. 2002 May;39(5):555-7. doi: 10.1067/mem.2002.123591.
No abstract available

MeSH terms

  • Adult
  • Anticoagulants* / administration & dosage
  • Anticoagulants* / adverse effects
  • Anticoagulants* / therapeutic use
  • Clinical Trials as Topic
  • Confidence Intervals
  • Emergency Medicine*
  • Evidence-Based Medicine*
  • Fibrinolytic Agents* / administration & dosage
  • Fibrinolytic Agents* / adverse effects
  • Fibrinolytic Agents* / therapeutic use
  • Follow-Up Studies
  • Heparin / therapeutic use
  • Heparin, Low-Molecular-Weight* / administration & dosage
  • Heparin, Low-Molecular-Weight* / adverse effects
  • Heparin, Low-Molecular-Weight* / therapeutic use
  • Humans
  • Odds Ratio
  • Practice Guidelines as Topic
  • Pulmonary Embolism / drug therapy
  • Systematic Reviews as Topic
  • Thromboembolism* / drug therapy
  • Time Factors
  • Venous Thrombosis* / drug therapy

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Heparin
  • Heparin, Low-Molecular-Weight